<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"
https:\/\/www.linkedin.com\/in\/charles-morris-35b52035\/ Neuraxpharm CHARLES MORRIS \u039f Charles Morris \u03ac\u03c1\u03c7\u03b9\u03c3\u03b5 \u03bd\u03b1 \u03b5\u03c1\u03b3\u03ac\u03b6\u03b5\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b7\u03bd Neuraxpharm \u03c9\u03c2 Head of Mergers & Acquisitions (\u03b5\u03c0\u03b9\u03ba\u03b5\u03c6\u03b1\u03bb\u03ae\u03c2 \u03c3\u03c5\u03b3\u03c7\u03c9\u03bd\u03b5\u03cd\u03c3\u03b5\u03c9\u03bd \u03ba\u03b1\u03b9 \u03b5\u03be\u03b1\u03b3\u03bf\u03c1\u03ce\u03bd) \u03c4\u03bf\u03bd \u0399\u03b1\u03bd\u03bf\u03c5\u03ac\u03c1\u03b9\u03bf \u03c4\u03bf\u03c5 2022. \u039f Charles \u03b5\u03af\u03bd\u03b1\u03b9 \u03c0\u03b5\u03c0\u03b5\u03b9\u03c1\u03b1\u03bc\u03ad\u03bd\u03bf\u03c2 \u03b5\u03c0\u03b1\u03b3\u03b3\u03b5\u03bb\u03bc\u03b1\u03c4\u03af\u03b1\u03c2 \u03c3\u03c4\u03bf\u03bd \u03c4\u03bf\u03bc\u03ad\u03b1 \u03c4\u03c9\u03bd \u03c3\u03c5\u03b3\u03c7\u03c9\u03bd\u03b5\u03cd\u03c3\u03b5\u03c9\u03bd \u03ba\u03b1\u03b9 \u03b5\u03be\u03b1\u03b3\u03bf\u03c1\u03ce\u03bd, \u03bc\u03b5 20 \u03c7\u03c1\u03cc\u03bd\u03b9\u03b1 \u03b5\u03bc\u03c0\u03b5\u03b9\u03c1\u03af\u03b1\u03c2 \u03c3\u03c4\u03b7\u03bd \u03b5\u03c0\u03b5\u03bd\u03b4\u03c5\u03c4\u03b9\u03ba\u03ae \u03c4\u03c1\u03b1\u03c0\u03b5\u03b6\u03b9\u03ba\u03ae \u03ba\u03b1\u03b9 \u03c4\u03b9\u03c2 \u03b5\u03c4\u03b1\u03b9\u03c1\u03b9\u03ba\u03ad\u03c2 \u03c3\u03c5\u03b3\u03c7\u03c9\u03bd\u03b5\u03cd\u03c3\u03b5\u03b9\u03c2\/\u03b5\u03be\u03b1\u03b3\u03bf\u03c1\u03ad\u03c2 \u03c3\u03c4\u03bf\u03bd \u03c6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03c5\u03c4\u03b9\u03ba\u03cc \u03ba\u03bb\u03ac\u03b4\u03bf, \u03c3\u03b5 \u03c0\u03bf\u03bb\u03bb\u03ad\u03c2 \u03c7\u03ce\u03c1\u03b5\u03c2, \u03bc\u03b5\u03c4\u03b1\u03be\u03cd […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1998,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-26606","page","type-page","status-publish","hentry"],"yoast_head":"\n
MIGUEL BARRERO - Neuraxpharm GR<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n